Cinesteam® Revolutionizes Care for Diabetic Foot Ulcers with Odor Control Solutions

Addressing the Challenges of Diabetic Foot Ulcers

In a remarkable initiative, Cinesteam® is making strides in the field of diabetic care, especially on World Diabetes Day, which falls on November 14th. Their commitment shines through in their efforts to support individuals battling diabetic foot ulcers (DFUs), a condition particularly prevalent in North America.
Diabetic foot ulcers are open sores that can develop on the feet of individuals with diabetes, often making it challenging for them to maintain their quality of life. Reports indicate that approximately 19% to 34% of those living with diabetes may experience a DFU at some point during their lives, but the complications do not stop there.
Infections can arise, resulting in over half of the ulcers becoming infected, and among those infections, there lies the risk of severe consequences, including amputation. A staggering 20% of individuals may also face additional complications, such as osteomyelitis, which is inflammation of the bone or bone marrow.
What often gets overlooked in the treatment of diabetic foot ulcers is the issue of malodor, which can stem from the infections and significantly impact a patient's well-being. Clémence Desjardin, Director of Operations and Business Development at Cemag Care, part of the Cinesteam® team, articulated the common oversight: "With so many other potential complications, it's easy to forget that malodor is a common complication with diabetic foot ulcers, as well."
To tackle this specific problem, Cinesteam® has developed an innovative secondary dressing designed not only to manage wounds but to also neutralize unwanted odors. The product incorporates a unique formulation based on cinnamon, which effectively masks unpleasant smells without promoting wound healing. This unique focus allows Cinesteam® to provide a far-reaching solution to help those with DFUs navigate their conditions more gracefully.

A Comprehensive Approach Towards Diabetes Management

Recent themes from organizations like the World Health Organization and the Pan American Health Organization emphasize the importance of equitable access to treatment and comprehensive care for those diagnosed with diabetes. The campaign's tagline, "Breaking Barriers, Bridging Gaps," highlights the need for improved access to quality treatment options.
As part of this broader health conversation, Cinesteam® advocates a more comprehensive approach. Their secondary dressings not only provide relief from odor but also serve as a critical component in managing diabetes-related conditions. With diabetes patients often struggling with feelings of discomfort and social isolation due to their condition, effective odor management can significantly enhance their quality of life.

Embracing Innovation in Health Care

Founded in 2016 by Dr. André Ulmann, Cinesteam® represents a solution-driven spirit in healthcare. The French pharmaceutical company's commitment to innovative treatments is notable, considering they prioritize natural ingredients. The cinnamon-based formulation exemplifies a commitment to both efficacy and safety, meeting clinical ratings as a class one medical device.
Cinesteam® debuted in Europe in 2020 and is gradually reaching markets with significant need, demonstrating its potential to serve as a vital resource for diabetes management.

Conclusion

As we continue recognizing the challenges posed by diabetes, it is essential to shed light on solutions like those offered by Cinesteam®. Their innovative secondary dressings stand out as a beacon of hope, combining healthcare necessity with a heightened focus on quality of life. Addressing both the medical and social dimensions of diabetic foot ulcers, Cinesteam® provides an avenue for patients to reclaim their confidence and comfort in day-to-day life.